This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

T3_1_6_2a

2011 National Healthcare Quality and Disparities Reports

The National Healthcare Quality Report (NHQR) is a comprehensive national overview of quality of health care in the United States. It is organized around four dimensions of quality of care: effectiveness, patient safety, timeliness, and patient centeredness.

Table 3_1_6.2aEnd stage renal disease patients age 18 and over who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy,a by race, United States, 2008

Total

White

Black

Asian

AI/AN

Population group

Percent

SE

Percent

SE

Percent

SE

Percent

SE

Percent

SE

Total

28.3

0.2

30.0

0.2

24.5

0.3

26.3

0.7

27.8

1.4

Age

18-44

23.8

0.4

26.3

0.5

20.6

0.6

22.6

1.7

25.7

3.2

45-64

27.2

0.2

29.3

0.3

23.4

0.4

26.2

1.1

26.0

1.9

65 and over

30.3

0.2

31.1

0.3

27.9

0.5

27.5

1.0

31.7

2.5

Gender

Male

28.1

0.2

30.0

0.2

23.1

0.4

26.8

0.9

27.6

2.0

Female

28.5

0.2

30.0

0.3

26.0

0.4

25.6

1.0

27.9

2.0

a. Denominator includes all incident end stage renal disease patients age 18 and over with valid CMS-2728 Medical Evidence form and a nonmissing value for the question: Did you see a nephrologist at all? Numerator includes those who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy.

Key: AI/AN: American Indian or Alaska Native; SE: standard error.

Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Renal Data System.